Results 221 to 230 of about 664,442 (399)

Senkyunolide I Improves Septicemia‐Induced Brain Dysfunction via Regulating Nrf2 and Astrocyte Activity.

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Senkyunolide I (Sen I) has a protective effect on the blood–brain barrier (BBB) in rats with sepsis‐associated encephalopathy (SAE). This study investigated whether Sen I regulates Nrf2 to ameliorate sepsis‐induced brain dysfunction (SIBD). Sixty rats were randomly assigned into Sham group, SAE group (Model group), SAE + Sen I group (72 mg/kg,
Haohao Cao, Tao Liu, Meixia Xu
wiley   +1 more source

Circulating Interleukin-6 Levels and Timing of Acute Ischemic Stroke Onset. [PDF]

Ann Clin Transl Neurol
Kowalski RG, Ledreux A, Violette JE, Paustian W, Sillau S, Thompson JA, Neumann RT, Ornelas D, Monte AA, Dylla L, Ginde AA, Farcas AM, Coughlan CM, Jones WJ, Grotta JC, Graner MW.   +15 more
europepmc   +1 more source

Predictors for Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Acute Ischemic Stroke

Stroke, 2017
Y. Hao, Dong Yang, Huaiming Wang, W. Zi, Meng Zhang, Y. Geng, Zhiming Zhou, Wei Wang, Haowen Xu, X. Tian, P. Lv, Yuxiu Liu, Y. Xiong, Xinfeng Liu, Gelin Xu, Chengchun Liu, Zongjie Shi, Jinhua Zhang, Hang Lin, Min Lin, Zhen-Di Hu, Xiaorong Deng, Y. Wan, Jiandong Zhang, Zhonghua Shi, Mi-rui Qu, Xianjun Huang, Tao Quan, S. Guan, Lin Chen, Xiaobo Li, Shui-ping Wang, Shi-quan Yang, Wen-hua Liu, D. Wei, Zhen Wang, Xintong Liu, F. Guo, Shu Yang, D. Zheng, Xinyu Wu, Youfu Zeng, M. Tu, P. Jin, Yong Liu, Hua Li, J. Fang, G. Xiao   +47 more
semanticscholar   +1 more source

Acute kidney injury and morbi‐mortality associated with “triple whammy” combination: Systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Aims “Triple whammy” (TW) refers to the concomitant use of diuretics, renin‐angiotensin‐aldosterone system inhibitors (RAASI) and non‐steroidal anti‐inflammatory drugs (NSAIDs). The aim of this article is to analyse the association between TW exposure and acute kidney injury (AKI), among other morbi‐mortality outcomes.
Dulce María Calvo, Luis Carlos Saiz, Leire Leache, Maria Concepción Celaya, Marta Gutiérrez‐Valencia   +4 more
wiley   +1 more source

Oral microbiome dysbiosis in acute ischemic stroke and transient ischemic attack patients. [PDF]

PLoS One
Roongpiboonsopit D, Wairit S, Nithisathienchai C, Pakdee A, Cheibchalard T, Sayasathid J, Wilantho A, Tongsima S, Somboonna N.   +8 more
europepmc   +1 more source

Nitric Oxide–Related Brain Damage in Acute Ischemic Stroke

, 2000
José Castillo, R. Rama, Antoni Dávalos
openalex   +1 more source

Human Albumin Therapy of Acute Ischemic Stroke [PDF]

, 2001
Ludmila Belayev, Yitao Liu, Weizhao Zhao, Raul Busto, Myron D. Ginsberg   +4 more
openalex   +1 more source

RECAST (Remote Ischemic Conditioning After Stroke Trial): A Pilot Randomized Placebo Controlled Phase II Trial in Acute Ischemic Stroke

Stroke, 2017
T. England, A. Hedstrom, S. O’Sullivan, R. Donnelly, D. Barrett, Sarir Sarmad, N. Sprigg, P. Bath   +7 more
semanticscholar   +1 more source

An experimental medicine protocol for exploring the haemodynamic effects of dual agonism at the glucagon‐like peptide‐1 and glucagon receptor in healthy subjects

British Journal of Clinical Pharmacology, EarlyView.
Aims Glucagon‐like peptide‐1 (GLP‐1) and glucagon dual receptor agonists are in clinical development for a range of metabolic conditions, including type 2 diabetes and obesity. The cardiovascular actions at these receptors are well studied, but less is known about their combination.
James Goodman, Victoria E. Parker, Carmel M. McEniery, Giovanni Di Stefano, Annette Hubsch, Evangelia Vamvaka, Jo Helmy, Fotini Kaloyirou, Navazh Jalaludeen, Peter Barker, Lutz Jermutus, Joseph Cheriyan, Philip Ambery, Ian B. Wilkinson   +13 more
wiley   +1 more source

Untargeted metabolomic profiling in acute ischemic stroke patients with cerebral microbleeds. [PDF]

Front Neurol
Zhou L, Sun H, Li X, Han Q.
europepmc   +1 more source